|
Name |
Accession |
Description |
Interval |
E-value |
| PRK13059 |
PRK13059 |
putative lipid kinase; Reviewed |
1-292 |
5.61e-134 |
|
putative lipid kinase; Reviewed
Pssm-ID: 183858 Cd Length: 295 Bit Score: 380.92 E-value: 5.61e-134
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 1 MDKALLVYNPFSGDRGIANKLDYILERFQQKDILLQPYRIMEGCGKNISDLLTEGSYKFVISSGGDGTLNFICNIIMKNN 80
Cdd:PRK13059 1 MKKVKFIYNPYSGENAIISELDKVIRIHQEKGYLVVPYRISLEYDLKNAFKDIDESYKYILIAGGDGTVDNVVNAMKKLN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 81 LSVPMGIIPAGTCNDFASILNIPTSVEECVDIILKGRTVDVDVGVVDDRiYFLSSCAGGVFVDVSFSTDGELKKNLGALA 160
Cdd:PRK13059 81 IDLPIGILPVGTANDFAKFLGMPTDIGEACEQILKSKPKKVDLGKINDK-YFINVASTGLFTDVSQKTDVNLKNTIGKLA 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 161 YYLKALTEMASMKPFRVTIETEEEIFEDDILLFCILNGNQAGGFHNLMDAVYDDGLMDIVIIKDCRKIELPAIFYKVINN 240
Cdd:PRK13059 160 YYLKGLEELPNFRKLKVKVTSEEVNFDGDMYLMLVFNGQTAGNFNLAYKAEVDDGLLDVIIIKACPIIDLIPLFIKVLKG 239
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|...
gi 551232666 241 ELQNDKN-VVTIRTNRCTIKSSKEIVLSIDGEKGPTLPVEVKFINKALKVFAA 292
Cdd:PRK13059 240 EHLEDVNgLIYFKTDKLEIESNEEIVTDIDGERGPDFPLNIECIKGGLKVLGI 292
|
|
| LCB5 |
COG1597 |
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ... |
1-291 |
8.87e-65 |
|
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];
Pssm-ID: 441205 [Multi-domain] Cd Length: 295 Bit Score: 205.09 E-value: 8.87e-65
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 1 MDKALLVYNPFSGDRGIANKLDYILERFQQKDILLQPYRIM-EGCGKNISDLLTEGSYKFVISSGGDGTLNFICNIIMKN 79
Cdd:COG1597 2 MMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETEsPGDATELAREAAAEGADLVVAAGGDGTVNEVANGLAGT 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 80 NlsVPMGIIPAGTCNDFASILNIPTSVEECVDIILKGRTvdvdvgvvdDRI--------YFLSSCAGGVFVDVSFSTDGE 151
Cdd:COG1597 82 G--PPLGILPLGTGNDFARALGIPLDPEAALEALLTGRT---------RRIdlgrvngrYFLNVAGIGFDAEVVERANRA 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 152 LKKNLGALAYYLKALTEMASMKPFRVTIETEEEIFEDDILLFCILNGNQAGGFHNLM-DAVYDDGLMDIVIIKDCRKIEL 230
Cdd:COG1597 151 LKRRLGKLAYVLAALRALLRYRPFRLRIELDGEEIEGEALLVAVGNGPYYGGGLRLApDASLDDGLLDVVVVRPLSRLRL 230
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 551232666 231 PAIFYKVINNELQNDKNVVTIRTNRCTIKSSKEIVLSIDGEK-GPTLPVEVKFINKALKVFA 291
Cdd:COG1597 231 LRLLPRLLRGRHLRHPGVRYFRAREVEIESDRPLPVQLDGEPlGLATPLEFEVLPGALRVLV 292
|
|
| TIGR00147 |
TIGR00147 |
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ... |
1-289 |
4.87e-36 |
|
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]
Pssm-ID: 161732 [Multi-domain] Cd Length: 293 Bit Score: 130.70 E-value: 4.87e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 1 MDKALLVYNPFSGDRGIANKLDYILERFQQKDILLQpYRIMEGCGKNISDLLTEGSYKF--VISSGGDGTLNFICNIIMK 78
Cdd:TIGR00147 1 MAEAPAILNPTAGKSNDNKPLREVIMLLREEGMEIH-VRVTWEKGDAARYVEEARKFGVdtVIAGGGDGTINEVVNALIQ 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 79 NNLSVPMGIIPAGTCNDFASILNIPTSVEECVDIILKGRTVDVDVGVVDDRIYFLSSCAGGVFVDVSFSTDGELKKNLGA 158
Cdd:TIGR00147 80 LDDIPALGILPLGTANDFARSLGIPEDLDKAAKLVIAGDARAIDMGQVNKQYCFINMAGGGFGTEITTETPEKLKAALGS 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 159 LAYYLKALTEMASMKPFRVTIETEEEIFEDDILLFCILNGNQAGGFHNLM-DAVYDDGLMDIVIIKDCRKIELPAIFYKV 237
Cdd:TIGR00147 160 LSYILSGLMRMDTLQPFRCEIRGEGEHWQGEAVVFLVGNGRQAGGGQKLApDASINDGLLDLRIFTNDNLLPALVLTLMS 239
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|..
gi 551232666 238 INNELQNDKNVVTIRTNRCTIKSSKEIVLSIDGEKGPTLPVEVKFINKALKV 289
Cdd:TIGR00147 240 DEGKHTDNPNIIYGKASRIDIQTPHKITFNLDGEPLGGTPFHIEILPAHLRC 291
|
|
| DAGK_cat |
pfam00781 |
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ... |
3-118 |
9.02e-23 |
|
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.
Pssm-ID: 425868 [Multi-domain] Cd Length: 125 Bit Score: 90.72 E-value: 9.02e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 3 KALLVYNPFSGDRGIANKLDYILERFQQKDILLQPYRI-MEGCGKNISDLLTEGSYKFVISSGGDGTLNFICNIIMKNNL 81
Cdd:pfam00781 1 KLLVIVNPKSGGGKGKKLLRKVRPLLNKAGVEVELVLTeGPGDALELAREAAEDGYDRIVVAGGDGTVNEVLNGLAGLAT 80
|
90 100 110
....*....|....*....|....*....|....*..
gi 551232666 82 SVPMGIIPAGTCNDFASILNIPTSVEECVDIILKGRT 118
Cdd:pfam00781 81 RPPLGIIPLGTGNDFARALGIPGDPEEALEAILKGQT 117
|
|
| DAGKc |
smart00046 |
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ... |
5-104 |
7.71e-09 |
|
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.
Pssm-ID: 214487 [Multi-domain] Cd Length: 124 Bit Score: 53.07 E-value: 7.71e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 5 LLVYNPFSGDrgiaNKLDYILERFQqkdILLQPYRIME----GCGKNISDLLTEGSYKFVISSGGDGTLNFICNIIMKNN 80
Cdd:smart00046 1 LVFVNPKSGG----GKGEKLLRKFR---LLLNPRQVFDltkkGPAVALVIFRDVPDFNRVLVCGGDGTVGWVLNALDKRE 73
|
90 100
....*....|....*....|....*..
gi 551232666 81 L---SVPMGIIPAGTCNDFASILNIPT 104
Cdd:smart00046 74 LplpEPPVAVLPLGTGNDLARSLGWGG 100
|
|
|
|
Name |
Accession |
Description |
Interval |
E-value |
| PRK13059 |
PRK13059 |
putative lipid kinase; Reviewed |
1-292 |
5.61e-134 |
|
putative lipid kinase; Reviewed
Pssm-ID: 183858 Cd Length: 295 Bit Score: 380.92 E-value: 5.61e-134
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 1 MDKALLVYNPFSGDRGIANKLDYILERFQQKDILLQPYRIMEGCGKNISDLLTEGSYKFVISSGGDGTLNFICNIIMKNN 80
Cdd:PRK13059 1 MKKVKFIYNPYSGENAIISELDKVIRIHQEKGYLVVPYRISLEYDLKNAFKDIDESYKYILIAGGDGTVDNVVNAMKKLN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 81 LSVPMGIIPAGTCNDFASILNIPTSVEECVDIILKGRTVDVDVGVVDDRiYFLSSCAGGVFVDVSFSTDGELKKNLGALA 160
Cdd:PRK13059 81 IDLPIGILPVGTANDFAKFLGMPTDIGEACEQILKSKPKKVDLGKINDK-YFINVASTGLFTDVSQKTDVNLKNTIGKLA 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 161 YYLKALTEMASMKPFRVTIETEEEIFEDDILLFCILNGNQAGGFHNLMDAVYDDGLMDIVIIKDCRKIELPAIFYKVINN 240
Cdd:PRK13059 160 YYLKGLEELPNFRKLKVKVTSEEVNFDGDMYLMLVFNGQTAGNFNLAYKAEVDDGLLDVIIIKACPIIDLIPLFIKVLKG 239
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|...
gi 551232666 241 ELQNDKN-VVTIRTNRCTIKSSKEIVLSIDGEKGPTLPVEVKFINKALKVFAA 292
Cdd:PRK13059 240 EHLEDVNgLIYFKTDKLEIESNEEIVTDIDGERGPDFPLNIECIKGGLKVLGI 292
|
|
| LCB5 |
COG1597 |
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ... |
1-291 |
8.87e-65 |
|
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];
Pssm-ID: 441205 [Multi-domain] Cd Length: 295 Bit Score: 205.09 E-value: 8.87e-65
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 1 MDKALLVYNPFSGDRGIANKLDYILERFQQKDILLQPYRIM-EGCGKNISDLLTEGSYKFVISSGGDGTLNFICNIIMKN 79
Cdd:COG1597 2 MMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETEsPGDATELAREAAAEGADLVVAAGGDGTVNEVANGLAGT 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 80 NlsVPMGIIPAGTCNDFASILNIPTSVEECVDIILKGRTvdvdvgvvdDRI--------YFLSSCAGGVFVDVSFSTDGE 151
Cdd:COG1597 82 G--PPLGILPLGTGNDFARALGIPLDPEAALEALLTGRT---------RRIdlgrvngrYFLNVAGIGFDAEVVERANRA 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 152 LKKNLGALAYYLKALTEMASMKPFRVTIETEEEIFEDDILLFCILNGNQAGGFHNLM-DAVYDDGLMDIVIIKDCRKIEL 230
Cdd:COG1597 151 LKRRLGKLAYVLAALRALLRYRPFRLRIELDGEEIEGEALLVAVGNGPYYGGGLRLApDASLDDGLLDVVVVRPLSRLRL 230
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 551232666 231 PAIFYKVINNELQNDKNVVTIRTNRCTIKSSKEIVLSIDGEK-GPTLPVEVKFINKALKVFA 291
Cdd:COG1597 231 LRLLPRLLRGRHLRHPGVRYFRAREVEIESDRPLPVQLDGEPlGLATPLEFEVLPGALRVLV 292
|
|
| PRK13337 |
PRK13337 |
putative lipid kinase; Reviewed |
1-284 |
7.18e-48 |
|
putative lipid kinase; Reviewed
Pssm-ID: 183982 [Multi-domain] Cd Length: 304 Bit Score: 161.75 E-value: 7.18e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 1 MDKALLVYNPFSGDRGIANKLDYILERFQQKDILLQPYRIM-EGCGKNISDLLTEGSYKFVISSGGDGTLNFICNIIMKN 79
Cdd:PRK13337 1 MKRARIIYNPTSGRELFKKNLPDVLQKLEQAGYETSAHATTgPGDATLAAERAVERKFDLVIAAGGDGTLNEVVNGIAEK 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 80 NLSVPMGIIPAGTCNDFASILNIPTSVEECVDIILKGRTVDVDVGVVDDRiYFLSSCAGGVFVDVSFSTDGELKKNLGAL 159
Cdd:PRK13337 81 ENRPKLGIIPVGTTNDFARALHVPRDIEKAADVIIEGHTVPVDIGKANNR-YFINIAGGGRLTELTYEVPSKLKTMLGQL 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 160 AYYLKALTEMASMKPFRVTIETEEEIFEDDILLFCILNGNQAGGFHNLM-DAVYDDGLMDIVIIKDCRKIELPAIFYKVI 238
Cdd:PRK13337 160 AYYLKGIEMLPSLKATDVRIEYDGKLFQGEIMLFLLGLTNSVGGFEKLApDASLDDGYFDLIIVKKANLAELIHIATLAL 239
|
250 260 270 280
....*....|....*....|....*....|....*....|....*.
gi 551232666 239 NNELQNDKNVVTIRTNRCTIKSSKEIVLSIDGEKGPTLPVEvkFIN 284
Cdd:PRK13337 240 RGEHIKHPKVIYTKANRIKVSSFDKMQLNLDGEYGGKLPAE--FEN 283
|
|
| TIGR00147 |
TIGR00147 |
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ... |
1-289 |
4.87e-36 |
|
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]
Pssm-ID: 161732 [Multi-domain] Cd Length: 293 Bit Score: 130.70 E-value: 4.87e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 1 MDKALLVYNPFSGDRGIANKLDYILERFQQKDILLQpYRIMEGCGKNISDLLTEGSYKF--VISSGGDGTLNFICNIIMK 78
Cdd:TIGR00147 1 MAEAPAILNPTAGKSNDNKPLREVIMLLREEGMEIH-VRVTWEKGDAARYVEEARKFGVdtVIAGGGDGTINEVVNALIQ 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 79 NNLSVPMGIIPAGTCNDFASILNIPTSVEECVDIILKGRTVDVDVGVVDDRIYFLSSCAGGVFVDVSFSTDGELKKNLGA 158
Cdd:TIGR00147 80 LDDIPALGILPLGTANDFARSLGIPEDLDKAAKLVIAGDARAIDMGQVNKQYCFINMAGGGFGTEITTETPEKLKAALGS 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 159 LAYYLKALTEMASMKPFRVTIETEEEIFEDDILLFCILNGNQAGGFHNLM-DAVYDDGLMDIVIIKDCRKIELPAIFYKV 237
Cdd:TIGR00147 160 LSYILSGLMRMDTLQPFRCEIRGEGEHWQGEAVVFLVGNGRQAGGGQKLApDASINDGLLDLRIFTNDNLLPALVLTLMS 239
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|..
gi 551232666 238 INNELQNDKNVVTIRTNRCTIKSSKEIVLSIDGEKGPTLPVEVKFINKALKV 289
Cdd:TIGR00147 240 DEGKHTDNPNIIYGKASRIDIQTPHKITFNLDGEPLGGTPFHIEILPAHLRC 291
|
|
| PRK13055 |
PRK13055 |
putative lipid kinase; Reviewed |
1-291 |
2.23e-35 |
|
putative lipid kinase; Reviewed
Pssm-ID: 237282 [Multi-domain] Cd Length: 334 Bit Score: 129.73 E-value: 2.23e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 1 MDKALLVYNPFSGDRGIANKLdyilerfqqKDILlqpyRIMEGCG---------------KNISDLLTEGSYKFVISSGG 65
Cdd:PRK13055 2 QKRARLIYNPTSGQEIMKKNV---------ADIL----DILEQAGyetsafqttpepnsaKNEAKRAAEAGFDLIIAAGG 68
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 66 DGTLNFICNIIMKNNLSVPMGIIPAGTCNDFASILNIP-TSVEECVDIILKGRTVDVDVGVVDDRIYFLSSCAGGVFVDV 144
Cdd:PRK13055 69 DGTINEVVNGIAPLEKRPKMAIIPAGTTNDYARALKIPrDNPVEAAKVILKNQTIKMDIGRANEDKYFINIAAGGSLTEL 148
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 145 SFSTDGELKKNLGALAYYLKALTEMASMKPFRVTIETEEEIFEDDILLFCILNGNQAGGFHNLM-DAVYDDGLMDIVIIK 223
Cdd:PRK13055 149 TYSVPSQLKSMFGYLAYLAKGAELLPRVSPVPVRITYDEGVFEGKISMFFLALTNSVGGFEQIVpDAKLDDGKFTLIIVK 228
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 551232666 224 DCRKIELPAIFYKVINNELQ-NDKNVVTIRTNRCTIKS--SKEIVLSIDGEKGPTLPVEVKFINKALKVFA 291
Cdd:PRK13055 229 TANLFELLHLMALILNGGKHiDDPRVIYIKTSKLTIEPlgDDRLMVNLDGEYGGDAPMTFENLKQHIEFFA 299
|
|
| PRK13054 |
PRK13054 |
lipid kinase; Reviewed |
60-271 |
2.46e-32 |
|
lipid kinase; Reviewed
Pssm-ID: 237281 [Multi-domain] Cd Length: 300 Bit Score: 121.13 E-value: 2.46e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 60 VISSGGDGTLNFICNIIMKNNLSVP--MGIIPAGTCNDFASILNIPTSVEECVDIILKGRTVDVDVGVVDDRIYFLSSCA 137
Cdd:PRK13054 60 VIAGGGDGTINEVATALAQLEGDARpaLGILPLGTANDFATAAGIPLEPDKALKLAIEGRAQPIDLARVNDRTYFINMAT 139
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 138 GGVFVDVSFSTDGELKKNLGALAYYLKALTEMASMKPFRVTIETEEEIFEDDILLFCILNGNQAGGFHNLM-DAVYDDGL 216
Cdd:PRK13054 140 GGFGTRVTTETPEKLKAALGGVAYLIHGLMRMDTLKPDRCEIRGPDFHWQGDALVIGIGNGRQAGGGQQLCpEALINDGL 219
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|....*
gi 551232666 217 MDIVIIKDCRKIeLPAIFYKvINNELQNDKNVVTIRTNRCTIKSSKEIVLSIDGE 271
Cdd:PRK13054 220 LDLRILPAPQEL-LPTLLST-LTGGSEDNPNIIRARLPWLEIQAPHELTFNLDGE 272
|
|
| PRK00861 |
PRK00861 |
putative lipid kinase; Reviewed |
1-291 |
2.33e-28 |
|
putative lipid kinase; Reviewed
Pssm-ID: 234850 [Multi-domain] Cd Length: 300 Bit Score: 110.48 E-value: 2.33e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 1 MDKALLVYNPFSGDRGIANKLDYILERFQQK---DILL-QPYRIMEGCGKnisDLLTEGSyKFVISSGGDGTLNFICNII 76
Cdd:PRK00861 2 TRSACLIFNPVAGQGNPEVDLALIRAILEPEmdlDIYLtTPEIGADQLAQ---EAIERGA-ELIIASGGDGTLSAVAGAL 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 77 MKNNlsVPMGIIPAGTCNDFASILNIPTSVEECVDIILKGRTvdvdvgvvddRIYFLSSCAG---------GVFVDVSFS 147
Cdd:PRK00861 78 IGTD--IPLGIIPRGTANAFAAALGIPDTIEEACRTILQGKT----------RRVDVAYCNGqpmillagiGFEAETVEE 145
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 148 TDGELKKNLGALAYYLKALTEMASMKPFRVTIETEEEIFEDDILLFCILNGNQ-----AGGFHNLmdaVYDDGLMDIVII 222
Cdd:PRK00861 146 ADREAKNRFGILAYILSGLQQLRELESFEVEIETEDQIITTNAVAVTVANAAPptsvlAQGPGAV---IPDDGLLDVTIV 222
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 551232666 223 KDCRKIELPAIFYKVI-----NNELQNDkNVVTIRTNRCTIKSSKEIVLSIDGEKGPTLPVEVKFINKALKVFA 291
Cdd:PRK00861 223 APKNLAEAVAASYHLLqtalqGNPAERD-DIGYLRAKQVKITTDPPQKVVIDGEVVGTTPIEIECLPRSLKVFA 295
|
|
| DAGK_cat |
pfam00781 |
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ... |
3-118 |
9.02e-23 |
|
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.
Pssm-ID: 425868 [Multi-domain] Cd Length: 125 Bit Score: 90.72 E-value: 9.02e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 3 KALLVYNPFSGDRGIANKLDYILERFQQKDILLQPYRI-MEGCGKNISDLLTEGSYKFVISSGGDGTLNFICNIIMKNNL 81
Cdd:pfam00781 1 KLLVIVNPKSGGGKGKKLLRKVRPLLNKAGVEVELVLTeGPGDALELAREAAEDGYDRIVVAGGDGTVNEVLNGLAGLAT 80
|
90 100 110
....*....|....*....|....*....|....*..
gi 551232666 82 SVPMGIIPAGTCNDFASILNIPTSVEECVDIILKGRT 118
Cdd:pfam00781 81 RPPLGIIPLGTGNDFARALGIPGDPEEALEAILKGQT 117
|
|
| PRK13057 |
PRK13057 |
lipid kinase; |
59-291 |
3.17e-22 |
|
lipid kinase;
Pssm-ID: 183857 [Multi-domain] Cd Length: 287 Bit Score: 93.44 E-value: 3.17e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 59 FVISSGGDGTLNFICNIIMKNNLsvPMGIIPAGTCNDFASILNIPTSVEECVDIILKGRTvdvdvgvvdDRI-------- 130
Cdd:PRK13057 53 LVIVGGGDGTLNAAAPALVETGL--PLGILPLGTANDLARTLGIPLDLEAAARVIATGQV---------RRIdlgwvngh 121
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 131 YFLSSCAGGVFVDVSFSTDGELKKNLGALAYYLKALTEMASMKPFRVTIETEEEIFEDDILLFCILNGNQAGG----FHn 206
Cdd:PRK13057 122 YFFNVASLGLSAELARRLTKELKRRWGTLGYAIAALRVLRRSRPFTAEIEHDGRTERVKTLQVAVGNGRYYGGgmtvAH- 200
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 207 lmDAVYDDGLMDI--VIIKDCRKieLPAIFYKVINNELQNDKNVVTIRTNRCTIKSSKEIVLSIDGEKGPTLPVEVKFIN 284
Cdd:PRK13057 201 --DATIDDGRLDLysLEVAHWWR--LLALLPALRRGRHGEWPDVRAFRTTELELRTRKPRPINTDGELTTYTPAHFRVLP 276
|
....*..
gi 551232666 285 KALKVFA 291
Cdd:PRK13057 277 KALRVLA 283
|
|
| PRK11914 |
PRK11914 |
diacylglycerol kinase; Reviewed |
60-289 |
4.05e-10 |
|
diacylglycerol kinase; Reviewed
Pssm-ID: 237021 [Multi-domain] Cd Length: 306 Bit Score: 59.41 E-value: 4.05e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 60 VISSGGDGTLNFICNIIMKNNlsVPMGIIPAGTCNDFASILNIPT-SVEECVDIILKGRTVDV----DVGVVDDRIYFLS 134
Cdd:PRK11914 68 LVVVGGDGVISNALQVLAGTD--IPLGIIPAGTGNDHAREFGIPTgDPEAAADVIVDGWTETVdlgrIQDDDGIVKWFGT 145
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 135 SCAGGVFVDVSFSTDgELKKNLGALAYYLKALTEMASMK--PFRVtIETEEEIFEDDILLFCILNGNQAGGFHNLM-DAV 211
Cdd:PRK11914 146 VAATGFDSLVTDRAN-RMRWPHGRMRYNLAMLAELSKLRplPFRL-VLDGTEEIVTDLTLAAFGNTRSYGGGMLICpNAD 223
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 551232666 212 YDDGLMDIVIIKDCRKIELPAIFYKVINNELQNDKNVVTIRTNRCTIKSSKeIVLSIDGEKGPTLPVEVKFINKALKV 289
Cdd:PRK11914 224 HTDGLLDITMVQSASRTRLLRLFPTVFKGTHVELDEVSTARAKTVHVECPG-INAYADGDFACPLPAEISAVPGALQI 300
|
|
| DAGKc |
smart00046 |
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ... |
5-104 |
7.71e-09 |
|
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.
Pssm-ID: 214487 [Multi-domain] Cd Length: 124 Bit Score: 53.07 E-value: 7.71e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 5 LLVYNPFSGDrgiaNKLDYILERFQqkdILLQPYRIME----GCGKNISDLLTEGSYKFVISSGGDGTLNFICNIIMKNN 80
Cdd:smart00046 1 LVFVNPKSGG----GKGEKLLRKFR---LLLNPRQVFDltkkGPAVALVIFRDVPDFNRVLVCGGDGTVGWVLNALDKRE 73
|
90 100
....*....|....*....|....*..
gi 551232666 81 L---SVPMGIIPAGTCNDFASILNIPT 104
Cdd:smart00046 74 LplpEPPVAVLPLGTGNDLARSLGWGG 100
|
|
| YegS_C |
pfam19279 |
YegS C-terminal NAD kinase beta sandwich-like domain; This entry represents the C-terminal ... |
156-291 |
8.37e-08 |
|
YegS C-terminal NAD kinase beta sandwich-like domain; This entry represents the C-terminal domain found in the YegS protein. It is related to the beta sandwich domain of NAD kinases. The structure of YegS reveals a two-domain protein with the active site crevice found between the two domains. The C-terminal domain contains 13 beta-strands and two alpha-helices. The likely substrate for YegS is phosphatidylglycerol.
Pssm-ID: 437111 Cd Length: 158 Bit Score: 50.66 E-value: 8.37e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 156 LGALAYYLKALTEMASMKPFRVTIETEEEIFEDDILLFCILNGNQAG-GFHNLMDAVYDDGLMDIVIIKDCRKIELPAIF 234
Cdd:pfam19279 22 PGALSYPAAALRALATFRPLRYRVTVDGEVREFSAALVAVANSGYYGgGMRIAPDARVDDGLLDVVVIEAASRRTLLRLL 101
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*..
gi 551232666 235 YKVINNELQNDKNVVTIRTNRCTIKSSKEIVLSIDGEKGPTLPVEVKFINKALKVFA 291
Cdd:pfam19279 102 PKVYDGRHVRLPQVEVLRGREVRIEADRPLPAGADGEVLGPLPVRVEVLPGALRVLA 158
|
|
| PRK12361 |
PRK12361 |
hypothetical protein; Provisional |
3-292 |
4.30e-06 |
|
hypothetical protein; Provisional
Pssm-ID: 183473 [Multi-domain] Cd Length: 547 Bit Score: 47.69 E-value: 4.30e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 3 KALLVYNPFSGDRGIANKLDYILERFQQKdillqpYRI-MEGCGKNIS-DLLTEGSYK----FVISSGGDGTLNFICNII 76
Cdd:PRK12361 244 RAWLIANPVSGGGKWQEYGEQIQRELKAY------FDLtVKLTTPEISaEALAKQARKagadIVIACGGDGTVTEVASEL 317
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 77 MKNNLSvpMGIIPAGTCNDFASIL------NIPtsVEECVDIILKGRTVDVDVGVVDDRIYFLsscaggvFVDVSF---- 146
Cdd:PRK12361 318 VNTDIT--LGIIPLGTANALSHALfglgskLIP--VEQACDNIIQGHTQRIDTARCNDRLMLL-------LVGIGFeqkm 386
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 147 --STDGELKKNLGALAY---YLKALTEMASMK---------PFRVTIETeeeifeddillFCILNGN-------QAGGFH 205
Cdd:PRK12361 387 ieSADRERKNALGQLAYldgLWRAVNENETLTltvtlddaePQTISTHS-----------LVVANAApftsllaQGGGEP 455
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 551232666 206 NlmdavYDDGLMDIVIIKDCRKI--------ELpaIFYKVINNELQNdkNVVTIRTNRCTIKSSKEIVLSIDGEKGPTLP 277
Cdd:PRK12361 456 N-----MTDGLLDITWLDSGGEPgeqllslaEL--ALSGLGKEPEAN--KVHHAHAKKVTISSQKPIKYVIDGELFEDED 526
|
330
....*....|....*
gi 551232666 278 VEVKFINKALKVFAA 292
Cdd:PRK12361 527 LTIEVQPASLKVFVP 541
|
|
|